1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
Dispenzieri A: POEMS Syndrome: 2019 update on diagnosis, risk-stratification, and management . Am J
Hematol. 2019, 94:812-27. 10.1002/ajh.25495
Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES: The 2008 WHO classification of lymphoid
neoplasms and beyond: evolving concepts and practical applications. Blood. 2011, 117:5019-32.
10.1182/blood-2011-01-293050
Dao LN, Hanson CA, Dispenzieri A, Morice WG, Kurtin PJ, Hoyer JD: Bone marrow histopathology in POEMS
syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients. Blood.
2011, 117:6438-44. 10.1182/blood-2010-11-316935
Soubrier M, Dubost JJ, Serre AF, et al.: Growth factors in POEMS syndrome: evidence for a marked increase
in circulating vascular endothelial growth factor. Arthritis Rheum. 1997, 40:786-7. 10.1002/art.1780400430
De D, Halder S, Datta SS: POEMS syndrome with biclonal gammopathy: a rare association . J Clin Diagn Res.
2017, 11:XD12-3. 10.7860/JCDR/2017/24800.10265
Authier FJ, Belec L, Levy Y, Lefaucheur JP, Defer GL, Degos JD, Gherardi RK: All-trans-retinoic acid in
POEMS syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory
cytokines. Arthritis Rheum. 1996, 39:1423-6. 10.1002/art.1780390824
Ham JY, Suh JS, Lee WK, Song KE: POEMS syndrome with IgG-λ/IgA-κ biclonal gammopathy and abnormal
serum free light chain ratio: a case report. Ann Clin Lab Sci. 2015, 45:702-6.
Levinson SS: POEMS syndrome: importance of the clinical laboratory practitioner's role . Clin Chim Acta.
2012, 413:1800-7. 10.1016/j.cca.2012.06.032
Delalande S, Stojkovic T, Rose C, Millaire A, Hurtevent JF, Vermersch P: [Bilateral phrenic nerve paralysis,
dysautonomia and restrictive cardiomyopathy in a case of POEMS syndrome]. Rev Neurol (Paris). 2002,
158:737-40.
Stankowski-Drengler T, Gertz MA, Katzmann JA, et al.: Serum immunoglobulin free light chain
measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS
syndrome. Am J Hematol. 2010, 85:431-4. 10.1002/ajh.21707
Wang C, Su W, Zhang W, et al.: Serum immunoglobulin free light chain and heavy/light chain
measurements in POEMS syndrome. Ann Hematol. 2014, 93:1201-6. 10.1007/s00277-014-2019-y
Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA: Serum reference intervals and
diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for
detection of monoclonal light chains. Clin Chem. 2002, 48:1437-44. 10.1093/clinchem/48.9.1437
Nakayama-Ichiyama S, Yokote T, Hirata Y, et al.: Immunohistological diagnosis of plasma cell myeloma
based on cytoplasmic kappa/lambda ratio of CD138-positive plasma cells. Leuk Lymphoma. 2012, 53:22059. 10.3109/10428194.2012.685734
Gherardi RK, Bélec L, Soubrier M, et al.: Overproduction of proinflammatory cytokines imbalanced by their
antagonists in POEMS syndrome. Blood. 1996, 87:1458-65. 10.1182/blood.V87.4.1458.bloodjournal8741458
Dispenzieri A, Kyle RA, Lacy MQ, et al.: POEMS syndrome: definitions and long-term outcome. Blood. 2003,
101:2496-506. 10.1182/blood-2002-07-2299
Wang C, Huang XF, Cai QQ, et al.: Prognostic study for overall survival in patients with newly diagnosed
POEMS syndrome. Leukemia. 2017, 31:100-6. 10.1038/leu.2016.168
2022 Ainai et al. Cureus 14(5): e25153. DOI 10.7759/cureus.25153
11 of 11
...
論文の公開元へ
